pridopidine

BH3 interacting domain death agonist ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32508327 Additional Safety and Exploratory Efficacy Data at 48 and 60 Months from Open-HART, an Open-Label Extension Study of Pridopidine in Huntington Disease. 2020 3
2 33164941 Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study. 2020 3